Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

James W. Mier, Gloria Vachino, Jos W.M. van der Meer, Robert P. Numerof, Sharlene Adams, Joseph Gerard Cannon, Harry A. Bernheim, Michael B. Atkins, David R. Parkinson, Charles A. Dinarello

Research output: Contribution to journalArticle

172 Citations (Scopus)

Abstract

Fever is frequently observed in cancer patients treated with high-dose recombinant human interleukin-2 (rIL-2). The preincubation of rIL-2 with polymyxin B, an antibiotic that inhibits the biologic effects of endotoxins, did not diminish the pyrogenicity of IL-2 in New Zealand rabbits, indicating that IL-2-induced fever is not due to contaminating endotoxins. In contrast to interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon α, which cause fever through their effects on arachidonic acid metabolism in the hypothalamus, IL-2 was unable to induce prostaglandin E 2 synthesis in hypothalamic cells or fibroblasts in vitro, suggesting that IL-2 is not intrinsically pyrogenic. To determine if IL-2-induced fever is mediated indirectly through the generation of pyrogenic cytokines, culture supernatants from IL-2-stimulated human peripheral blood mononuclear cells were screened for the presence of pyrogens by direct injection into rabbits and by measuring the amounts of IL-1α, IL-1β, and TNFα by specific radioimmunoassays (RIA). All three cytokines were readily detected by RIA in these supernatants, which in turn caused fever when injected into rabbits. Furthermore, in six of six cancer patients treated with rIL-2, elevated levels of TNFα were detected in the plasma by RIA 2 hr after IL-2 administration. Plasma TNF levels increased from pretreatment values of 14±7 to 765±150 pg/ml 2 hr after an IL-2 injection. These results strongly implicate IL-2-induced pyrogenic cytokines, in particular TNFα, as a major cause of the fever and possibly other aspects of the acute-phase response associated with IL-2 therapy.

Original languageEnglish (US)
Pages (from-to)426-436
Number of pages11
JournalJournal of Clinical Immunology
Volume8
Issue number6
DOIs
StatePublished - Nov 1 1988

Fingerprint

Interleukin-2
Fever
Tumor Necrosis Factor-alpha
Neoplasms
Interleukin-1
Radioimmunoassay
Cytokines
Rabbits
Endotoxins
Pyrogens
Polymyxin B
Acute-Phase Reaction
Injections
Prostaglandins E
Arachidonic Acid
Interferons
Hypothalamus
Blood Cells
Fibroblasts
Anti-Bacterial Agents

Keywords

  • Interleukin-2
  • fever
  • tumor necrosis factor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Mier, J. W., Vachino, G., van der Meer, J. W. M., Numerof, R. P., Adams, S., Cannon, J. G., ... Dinarello, C. A. (1988). Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. Journal of Clinical Immunology, 8(6), 426-436. https://doi.org/10.1007/BF00916947

Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. / Mier, James W.; Vachino, Gloria; van der Meer, Jos W.M.; Numerof, Robert P.; Adams, Sharlene; Cannon, Joseph Gerard; Bernheim, Harry A.; Atkins, Michael B.; Parkinson, David R.; Dinarello, Charles A.

In: Journal of Clinical Immunology, Vol. 8, No. 6, 01.11.1988, p. 426-436.

Research output: Contribution to journalArticle

Mier, JW, Vachino, G, van der Meer, JWM, Numerof, RP, Adams, S, Cannon, JG, Bernheim, HA, Atkins, MB, Parkinson, DR & Dinarello, CA 1988, 'Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients', Journal of Clinical Immunology, vol. 8, no. 6, pp. 426-436. https://doi.org/10.1007/BF00916947
Mier, James W. ; Vachino, Gloria ; van der Meer, Jos W.M. ; Numerof, Robert P. ; Adams, Sharlene ; Cannon, Joseph Gerard ; Bernheim, Harry A. ; Atkins, Michael B. ; Parkinson, David R. ; Dinarello, Charles A. / Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. In: Journal of Clinical Immunology. 1988 ; Vol. 8, No. 6. pp. 426-436.
@article{d1c59dafb8594e71ad9c2a7e00ca8152,
title = "Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients",
abstract = "Fever is frequently observed in cancer patients treated with high-dose recombinant human interleukin-2 (rIL-2). The preincubation of rIL-2 with polymyxin B, an antibiotic that inhibits the biologic effects of endotoxins, did not diminish the pyrogenicity of IL-2 in New Zealand rabbits, indicating that IL-2-induced fever is not due to contaminating endotoxins. In contrast to interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon α, which cause fever through their effects on arachidonic acid metabolism in the hypothalamus, IL-2 was unable to induce prostaglandin E 2 synthesis in hypothalamic cells or fibroblasts in vitro, suggesting that IL-2 is not intrinsically pyrogenic. To determine if IL-2-induced fever is mediated indirectly through the generation of pyrogenic cytokines, culture supernatants from IL-2-stimulated human peripheral blood mononuclear cells were screened for the presence of pyrogens by direct injection into rabbits and by measuring the amounts of IL-1α, IL-1β, and TNFα by specific radioimmunoassays (RIA). All three cytokines were readily detected by RIA in these supernatants, which in turn caused fever when injected into rabbits. Furthermore, in six of six cancer patients treated with rIL-2, elevated levels of TNFα were detected in the plasma by RIA 2 hr after IL-2 administration. Plasma TNF levels increased from pretreatment values of 14±7 to 765±150 pg/ml 2 hr after an IL-2 injection. These results strongly implicate IL-2-induced pyrogenic cytokines, in particular TNFα, as a major cause of the fever and possibly other aspects of the acute-phase response associated with IL-2 therapy.",
keywords = "Interleukin-2, fever, tumor necrosis factor",
author = "Mier, {James W.} and Gloria Vachino and {van der Meer}, {Jos W.M.} and Numerof, {Robert P.} and Sharlene Adams and Cannon, {Joseph Gerard} and Bernheim, {Harry A.} and Atkins, {Michael B.} and Parkinson, {David R.} and Dinarello, {Charles A.}",
year = "1988",
month = "11",
day = "1",
doi = "10.1007/BF00916947",
language = "English (US)",
volume = "8",
pages = "426--436",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

AU - Mier, James W.

AU - Vachino, Gloria

AU - van der Meer, Jos W.M.

AU - Numerof, Robert P.

AU - Adams, Sharlene

AU - Cannon, Joseph Gerard

AU - Bernheim, Harry A.

AU - Atkins, Michael B.

AU - Parkinson, David R.

AU - Dinarello, Charles A.

PY - 1988/11/1

Y1 - 1988/11/1

N2 - Fever is frequently observed in cancer patients treated with high-dose recombinant human interleukin-2 (rIL-2). The preincubation of rIL-2 with polymyxin B, an antibiotic that inhibits the biologic effects of endotoxins, did not diminish the pyrogenicity of IL-2 in New Zealand rabbits, indicating that IL-2-induced fever is not due to contaminating endotoxins. In contrast to interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon α, which cause fever through their effects on arachidonic acid metabolism in the hypothalamus, IL-2 was unable to induce prostaglandin E 2 synthesis in hypothalamic cells or fibroblasts in vitro, suggesting that IL-2 is not intrinsically pyrogenic. To determine if IL-2-induced fever is mediated indirectly through the generation of pyrogenic cytokines, culture supernatants from IL-2-stimulated human peripheral blood mononuclear cells were screened for the presence of pyrogens by direct injection into rabbits and by measuring the amounts of IL-1α, IL-1β, and TNFα by specific radioimmunoassays (RIA). All three cytokines were readily detected by RIA in these supernatants, which in turn caused fever when injected into rabbits. Furthermore, in six of six cancer patients treated with rIL-2, elevated levels of TNFα were detected in the plasma by RIA 2 hr after IL-2 administration. Plasma TNF levels increased from pretreatment values of 14±7 to 765±150 pg/ml 2 hr after an IL-2 injection. These results strongly implicate IL-2-induced pyrogenic cytokines, in particular TNFα, as a major cause of the fever and possibly other aspects of the acute-phase response associated with IL-2 therapy.

AB - Fever is frequently observed in cancer patients treated with high-dose recombinant human interleukin-2 (rIL-2). The preincubation of rIL-2 with polymyxin B, an antibiotic that inhibits the biologic effects of endotoxins, did not diminish the pyrogenicity of IL-2 in New Zealand rabbits, indicating that IL-2-induced fever is not due to contaminating endotoxins. In contrast to interleukin-1 (IL-1), tumor necrosis factor (TNF), and interferon α, which cause fever through their effects on arachidonic acid metabolism in the hypothalamus, IL-2 was unable to induce prostaglandin E 2 synthesis in hypothalamic cells or fibroblasts in vitro, suggesting that IL-2 is not intrinsically pyrogenic. To determine if IL-2-induced fever is mediated indirectly through the generation of pyrogenic cytokines, culture supernatants from IL-2-stimulated human peripheral blood mononuclear cells were screened for the presence of pyrogens by direct injection into rabbits and by measuring the amounts of IL-1α, IL-1β, and TNFα by specific radioimmunoassays (RIA). All three cytokines were readily detected by RIA in these supernatants, which in turn caused fever when injected into rabbits. Furthermore, in six of six cancer patients treated with rIL-2, elevated levels of TNFα were detected in the plasma by RIA 2 hr after IL-2 administration. Plasma TNF levels increased from pretreatment values of 14±7 to 765±150 pg/ml 2 hr after an IL-2 injection. These results strongly implicate IL-2-induced pyrogenic cytokines, in particular TNFα, as a major cause of the fever and possibly other aspects of the acute-phase response associated with IL-2 therapy.

KW - Interleukin-2

KW - fever

KW - tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0024231234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024231234&partnerID=8YFLogxK

U2 - 10.1007/BF00916947

DO - 10.1007/BF00916947

M3 - Article

VL - 8

SP - 426

EP - 436

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 6

ER -